Buchanan Ingersoll & Rooney Adds IP Counsel in Life Sciences Industry Group
WASHINGTON (July 26, 2022) – Buchanan Ingersoll & Rooney continues its strategic growth with the addition of Dr. Mythili Markowski, who will be Counsel in the firm’s Intellectual Property (IP) section and based in Washington, DC. Dr. Markowski rejoins the firm from a global pharmaceutical company where she was a senior patent attorney.
She focuses her practice on intellectual property law, specifically patent prosecution and litigation for clients in the pharmaceutical and biotechnology industries. For more than 16 years, she has assisted a range of clients from single inventors to large corporations to help secure, protect, or litigate their intellectual property.
“We are happy to welcome Mythili back to Buchanan,” said Todd Walters, shareholder and Patent Office Litigation Chair. “Her scientific background and deep knowledge in the life sciences industry will be a great asset to our clients. She understands their real-world business needs and how to provide solutions through practical, effective legal services.”
In her IP litigation practice, she has been associated with a number of inter partes review and patent interference matters before the Patent Trial and Appeal Board on behalf of petitioners and patent owners. Her IP district court experience includes a special emphasis on pharmaceutical patent litigation under the Hatch-Waxman Act. She also maintains an IP counseling practice, which incorporates IP procurement, IP due diligence, as well as preparing all types of IP opinions, including patentability, freedom-to-operate, invalidity and non-infringement opinions. She has experience in tailoring IP protection plans for clients who balance trade secrets with patent portfolios.
“I am thrilled to be back with the impressive team at Buchanan,” said Dr. Markowski. “I look forward to working together to zealously advocate and create strategies on behalf of our clients to protect their IP.”
Dr. Markowski holds a bachelor’s degree in Molecular Biology and Biotechnology from McMaster University and she holds a law degree from The Catholic University of America, Columbus School of Law. She received her doctorate in Biophysics and Biophysical Chemistry from The Johns Hopkins University School of Medicine. Her graduate research was primarily focused on determining the three-dimensional structure of a protein involved in axon guidance, MICAL (Molecule Interacting with Cas-L). Dr. Markowski’s technical knowledge also includes molecular biology, protein biochemistry, powder X-ray crystallography, enzymology, neuroscience, biotechnology, nanotechnology, immunology and cell biology.